Log in
Enquire now
‌

US Patent 10370374 Heterocyclic compounds and uses thereof

Patent 10370374 was granted and assigned to Plexxikon Inc. on August, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Plexxikon Inc.
Plexxikon Inc.
0
Date Filed
May 11, 2018
0
Date of Patent
August 6, 2019
0
Patent Applicant
Plexxikon Inc.
Plexxikon Inc.
0
Patent Application Number
15977772
0
Patent Citations Received
‌
US Patent 12076322 Compounds and methods for kinase modulation, and indications therefor
0
‌
US Patent 10793561 1,8-naphthyridinone compounds and uses thereof
‌
US Patent 10899761 Heterocyclic compounds and uses thereof
0
‌
US Patent 11584756 Heterocyclic compounds as BET inhibitors
0
‌
US Patent 11028058 Heterocyclic compounds as adenosine antagonists
0
‌
US Patent 11254670 1,8-naphthyridinone compounds and uses thereof
‌
US Patent 11628176 Combinational drug therapies
0
‌
US Patent 11306071 Heterocyclic compounds as adenosine antagonists
‌
US Patent 11337976 Compounds and methods for kinase modulation, and indications therefor
‌
US Patent 11446287 Compounds and methods for EP300 or CBP modulation and indications therefor
•••
Patent Inventor Names
Wayne Spevak
0
Jiazhong Zhang
0
Prabha N. Ibrahim
0
Songyuan Shi
0
Yan Ma
0
Ben Powell
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10370374
0
Patent Primary Examiner
‌
Charanjit Aulakh
0

Find more entities like US Patent 10370374 Heterocyclic compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.